MASLD is the hepatic manifestation of the MS which is often associated with abnormal liver enzyme levels such as elevated levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) (10, 11). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.